Clinical Trial Update: A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402) [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study of preladenant (SCH 420814) for Parkinson's disease in Japanese patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• preladenant (preladenant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2016-10-11